HashiCorp Investor Presentation Deck slide image

HashiCorp Investor Presentation Deck

GAAP to Non-GAAP Reconciliations ($ Millions, except percentages) Total Revenue Total gross profit on a GAAP basis Add: Amortization of stock-based compensation of capitalized internal-use software Add: Stock-based compensation expense in cost of revenue¹ Non-GAAP gross profit Non-GAAP gross margin Total Revenue Operating Loss Add: Amortization of stock-based compensation of capitalized internal-use software Add: Stock-based compensation expense¹ Non-GAAP operating loss Non-GAAP operating margin Q1 $22.2 $17.9 $ $ 0.1 $ 18.0 81.0% - Q1 $22.2 FY2020 - Q2 Q3 Q4 $26.4 $33.5 $39.2 $20.9 $ $ 0.1 $ 21.0 80.0% - $27.1 $ $ 0.1 $ 27.2 81.0% FY2020 Q2 Q3 $26.4 $ 33.5 $31.5 $ $ 0.1 $ 31.6 81.0% - Q4 $39.2 $ (12.7) $ (14.2) $ (15.1) $ (14.3) $ $ $ $ $ 3.0 $ 2.2 $ 2.1 $ 2.1 $ (9.6) $ (12.0) $ (13.0) $ (12.1) -43.0% -46.0% -39.0% -31.0% FY2020 $ 121.3 $97.3 $ $ 0.5 $ 97.8 81.0% - FY2020 $ 121.3 $ (56.2) $ $ 9.5 $ (46.8) -39.0% Q1 $44.3 $35.6 $ $ 0.1 $35.8 81.0% - FY2021 Q2 $ 50.5 - $39.9 $ $ 1.0 $ 40.9 81.0% - Q1 $44.3 $ 50.5 Q2 Q3 Q4 $55.2 $61.8 FY2021 $44.9 $ 50.4 $ $ $ 0.1 $ 0.1 $ 45.0 $ 50.5 81.0% 82.0% - Q3 Q4 $55.2 $61.8 $ (19.1) $ (48.4) $ (9.3) $ (7.1) $ $ $ $ $ 1.9 $33.9 $ 1.7 $ 1.7 $ (17.2) $ (14.5) $ (7.6) $ (5.5) -39.0% -29.0% -14.0% -9.0% FY2021 $ 211.9 $170.8 $ $ 1.4 $ 172.2 81.0% FY2021 $211.9 $ (84.0) $ $39.2 $ (44.8) -21.0% Q1 $66.9 $ $ 0.1 $ 54.4 81.0% FY2022 $54.2 $62.2 $71.1 $ - Q2 Q3 $75.1 $82.2 $ 96.6 Q4 FY2022 69.8 $ $ $ 0.40 $ 0.1 $ 0.2 $ 13.5 $ 62.3 $71.3 $ 83.7 83.0% 87.0% 87.0% Q1 Q2 Q3 Q4 $ 66.9 $75.1 $82.2 $ 96.5 $ $ (15.4) $ (25.1) $ (21.5) $ (227.2) $ $ $ 0.4 $ 1.7 $ 1.5 $ 1.5 $195.7 $ (13.7) $ (23.6) $ (20.0) $ (31.1) -20.0% -31.0% -24.0% -32.0% 군 FY2022 $ 320.8 $ 257.3 $ 0.40 $ 13.9 $ 271.6 85.0% FY2022 $320.8 $ (289.2) $ 0.4 $ 200.4 $ (88.4) -28.0% 1. In connection with tender offers and secondary sales of our common stock, stock-based compensation expense for fiscal 2020 and fiscal 2021, included $1.5 million and $32.1 million of expense, respectively, related to the amount paid in excess of the estimated fair value of common stock as of the date of the transactions. FY2023 Q1 $ 100.9 $ 81.5 $ 0.17 $ 3.3 $ 85.0 84.2% FY2023 Q1 $100.9 $ (78.4) $ 0.2 $ 46.3 $ (32.0) -31.7% 54
View entire presentation